Search research articles
Contact Us
Filters
Showing results (41-50 of 251) with videos related to
Page
of 26
Sort By:
Expert Review of Clinical Immunology
|
June 5, 2013
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment
Bharath Wootla, Jens O Watzlawik, Aleksandar Denic, et al.
Journal of Medical Virology
|
January 23, 2015
Ebola virus: melatonin as a readily available treatment option
George Anderson, Michael Maes, Regina P Markus, et al.
Journal of the Neurological Sciences
|
February 7, 2018
Demyelination with preferential MAG loss: A complex message from MS paraffin blocks
Reza Rahmanzadeh, Mohammad Ali Sahraian, Ramin Rahmanzade, et al.
International Journal of Physical Medicine & Rehabilitation
|
September 6, 2016
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
Harika Dasari, Bharath Wootla, Arthur E Warrington, et al.
Expert Review of Neurotherapeutics
|
March 28, 2012
Need for a paradigm shift in therapeutic approaches to CNS injury
Bharath Wootla, Aleksandar Denic, Arthur E Warrington, et al.
Journal of Neuroinflammation
|
April 30, 2016
A monoclonal natural human IgM protects axons in the absence of remyelination
Bharath Wootla, Aleksandar Denic, Arthur E Warrington, et al.
Journal of Neuroimmunology
|
October 1, 2005
HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice
Meenakshi Khare, Ashutosh Mangalam, Moses Rodriguez, et al.
International Immunology
|
July 21, 2004
CD4+ T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice
Xiaoqi Lin, Xiaoxing Ma, Moses Rodriguez, et al.
CNS Drugs
|
June 25, 2011
Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network
Xiaohua Xu, Arthur E Warrington, Allan J Bieber, et al.
Journal of Nature and Science
|
July 23, 2016
A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients
Jens O Watzlawik, Meghan M Painter, Bharath Wootla, et al.
Page
of 26
Search research articles
Search
Showing results (41-50 of 251) with videos related to
Sort By:
Page
of 26
Expert Review of Clinical Immunology
|
June 5, 2013
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment
Bharath Wootla, Jens O Watzlawik, Aleksandar Denic, et al.
Journal of Medical Virology
|
January 23, 2015
Ebola virus: melatonin as a readily available treatment option
George Anderson, Michael Maes, Regina P Markus, et al.
Journal of the Neurological Sciences
|
February 7, 2018
Demyelination with preferential MAG loss: A complex message from MS paraffin blocks
Reza Rahmanzadeh, Mohammad Ali Sahraian, Ramin Rahmanzade, et al.
International Journal of Physical Medicine & Rehabilitation
|
September 6, 2016
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
Harika Dasari, Bharath Wootla, Arthur E Warrington, et al.
Expert Review of Neurotherapeutics
|
March 28, 2012
Need for a paradigm shift in therapeutic approaches to CNS injury
Bharath Wootla, Aleksandar Denic, Arthur E Warrington, et al.
Journal of Neuroinflammation
|
April 30, 2016
A monoclonal natural human IgM protects axons in the absence of remyelination
Bharath Wootla, Aleksandar Denic, Arthur E Warrington, et al.
Journal of Neuroimmunology
|
October 1, 2005
HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice
Meenakshi Khare, Ashutosh Mangalam, Moses Rodriguez, et al.
International Immunology
|
July 21, 2004
CD4+ T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice
Xiaoqi Lin, Xiaoxing Ma, Moses Rodriguez, et al.
CNS Drugs
|
June 25, 2011
Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network
Xiaohua Xu, Arthur E Warrington, Allan J Bieber, et al.
Journal of Nature and Science
|
July 23, 2016
A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients
Jens O Watzlawik, Meghan M Painter, Bharath Wootla, et al.
Page
of 26